TheEdgeResearch
Home / Stocks / BSPK

Bespoke Extracts, Inc. (BSPK)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▼ -22.22%
Market Cap
$7,877
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.07
52-Wk Range
0.0007-0.35
CEO
Michael R. Feinsod
Country
US
Currency
USD

Bespoke Extracts, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Aurora, CO, US. The stock last traded at $0.00, down 22.22% on the session, giving a market capitalisation of $7,877. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -48.5%. Its beta of 0.07 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.01
Price / Book
-0.00
EV / EBITDA
-3.52
Gross margin
48.4%
Operating margin
-41.1%
Net margin
-48.5%
Return on equity
Debt / equity
-0.58
Current ratio
0.11
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2008-02-04
Headquarters
Aurora, CO, US
About Bespoke Extracts, Inc.

Bespoke Extracts, Inc. offers a range of cannabidiol (CBD) products sourced from hemp. Their diverse inventory includes various CBD formulations, such as those infused with manuka honey, as well as lotions and balms. Additionally, the company provides CBD extracts available in capsule form, topical applications, and edible gummies. These items are sold directly to consumers through their dedicated e-commerce website, bespokeextracts.com. The business, which changed its name from DiMi Telematics International, Inc. to Bespoke Extracts, Inc. in March 2017, is headquartered in Denver, Colorado.

Comparable companies

Bespoke Extracts, Inc. is most often compared with the following Healthcare names:

ANTCFCVGRFEVIOGENPFHEMPKAYSKHRNFKOANLVRLFPBFFF
More research on BSPK
BSPK technical analysis BSPK TheEdge Score Compare against peers
Open full interactive analysis & DCF →